Show simple item record

dc.contributor.authorShaw, Bronwen E
dc.contributor.authorApperley, Jane F
dc.contributor.authorRussell, Nigel
dc.contributor.authorCraddock, Charles
dc.contributor.authorLiakopoulou, Effie F
dc.contributor.authorPotter, Mike N
dc.contributor.authorWynn, Robert F
dc.contributor.authorGibson, Brenda E
dc.contributor.authorPearce, Rachel M
dc.contributor.authorKirkland, Keiren E
dc.contributor.authorLee, Julia
dc.contributor.authorMadrigal, J Alejandro
dc.contributor.authorCook, Gordon
dc.contributor.authorByrne, Jennifer L
dc.date.accessioned2011-07-21T12:19:30Z
dc.date.available2011-07-21T12:19:30Z
dc.date.issued2011
dc.identifier.citationUnrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. 2011, 153 (2):244 Br J Haematolen
dc.identifier.issn00071048
dc.identifier.pmid21382020
dc.identifier.doi10.1111/j.1365-2141.2011.08615.x
dc.identifier.urihttp://hdl.handle.net/10541/136516
dc.language.isoenen
dc.titleUnrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.en
dc.typeArticleen
dc.contributor.departmentAnthony Nolan Trust, Londonen
dc.identifier.journalBritish Journal of Haematologyen


This item appears in the following Collection(s)

Show simple item record